Skip to main content


Young Innovations consistently adheres to a three-pronged strategy for growth – acquire, enhance and improve, which provides the foundation for continuing success.

Young Innovations was founded around 1900 and was a pioneer of US manufactured dental products. In modern history, Young Innovations was built through the 1990’s and early 2000’s through a series of mergers and acquisitions in a variety of dental segments. Young went public in 1997 and traded on the NASDAQ stock exchange under the ticker YDNT for over 15 years. In 2013, Young was acquired by Linden Capital Partners, a healthcare-focused private equity investment firm. In 2017, Linden Capital sold a majority interest to The Jordan Company, LP (“TJC”). TJC is a leading investment firm with a long history of partnering with management teams to help them build their businesses through a combination of strategic investments to drive organic growth and acquisitions.

Young Innovations continues to build on its rich legacy of manufacturing and supplying high-quality products designed to improve the clinical experience for dental professionals and patients. We believe in creating smiles and creating possibilities, and will continue to make history doing so!


Young Innovations strategy of Focused Excellence is designed to drive significant growth and opportunity, which delivers significant value for our stakeholders, including clinicians, business partners, employees and patients. At our core, we focus on high-quality and efficient manufacturing of branded clinical supplies and equipment. We seek out opportunities to grow our portfolio of brands and products through organic growth and acquisitions.

To achieve the greatest strategic focus, our business is separated into two divisions: manufactured products which are sold through dental distributors and products supplied directly to dental professionals. We also focus on partnering with other dental companies to provide them with products and solutions to support their growth. We are a lean, matrixed organization with dedicated employees with significant expertise and tenure.

We apply rigorous focus to all our activities, carefully selecting where best to spend our time. We execute aggressively on our stated goals and objectives across our business, and hold ourselves accountable to measurable results. It is through this Focused Excellence approach that we can continue creating smiles and creating possibilities.


Ken Serota

Chief Executive Officer

Michael Sherman

Chief Financial Officer

Brian Werner

Chief Quality & Operations Officer

Frank Whyte

VP & General Manager, Young International

Mark Peluse

VP of Global HR & Legal

Dan Garrick

VP of Corporate Development

John Frymark

VP of Global Product Strategy & New Product Development

Shouvik Dutta

VP of Information Technology

Scott Leece

VP of Business Process Optimization

Jose A. Espino

VP of Quality and Regulatory Affairs

Steve Clareen

VP General Manager, Oral Surgery

Brandon Arsenault

VP of Sales


John Jordan II

David Butler

John Straus

Barry Gallup, Jr.

Michael Farah

Bill Jellison

Gerard Moufflet

Mark Burggraaff

Close Menu

Young Innovations
Europe GmbH

Mittermaierstraße 31
69115 Heidelberg